C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/306.1
C07D 487/10 (2006.01) C07D 209/34 (2006.01) C07D 209/38 (2006.01) C07D 209/42 (2006.01)
Patent
CA 1182823
ABSTRACT The invention there provides a pharmaceutical composition comprising an aldose reductase inhibitory 1'-substituted-spiro[pyrrolidine-3,3'-indoline]-2,2', 5-trione of the formula:- Image I wherein Ra is (2-7C)alkyl or (3-7C)alkenyl, naphthyl- methyl or cinnamyl optionally bearing one or two halogeno nuclear substituents, or Ra is benzyl optionally bearing one or two substituents and benzene ring A optionally bears one or two substituents, trifluoro- methyl and nitro; or a salt thereof with a base affording ? pharmaceutically acceptable cation; or a non-toxic, biodegradable precursor thereof; together with a pharmaceutically a-ceptable diluent or carrier. The invention also provides novel compounds of formula I and processes for their manufacture. The compositions are of application in the treatment or prophylaxis of the side effects of diabetes or galactosemia.
402665
Brittain David R.
Wood Robin
Imperial Chemical Industries Plc
Smart & Biggar
LandOfFree
1'-substituted-spiro ¬pyrrolidine-3,3'-indoline|... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1'-substituted-spiro ¬pyrrolidine-3,3'-indoline|..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1'-substituted-spiro ¬pyrrolidine-3,3'-indoline|... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1277564